175 related articles for article (PubMed ID: 29848399)
1. Safety of ferumoxytol in children undergoing cardiac MRI under general anaesthesia.
Wise-Faberowski L; Velasquez N; Chan F; Vasanawala S; McElhinney DB; Ramamoorthy C
Cardiol Young; 2018 Jul; 28(7):916-921. PubMed ID: 29848399
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of ferumoxytol-enhanced neonatal and young infant cardiac MRI without general anesthesia.
Lai LM; Cheng JY; Alley MT; Zhang T; Lustig M; Vasanawala SS
J Magn Reson Imaging; 2017 May; 45(5):1407-1418. PubMed ID: 27678106
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic safety and efficacy of ferumoxytol as an intravenous contrast agents in pediatric patients and young adults.
Ning P; Zucker EJ; Wong P; Vasanawala SS
Magn Reson Imaging; 2016 Feb; 34(2):152-8. PubMed ID: 26518061
[TBL] [Abstract][Full Text] [Related]
4. MRI with ferumoxytol: A single center experience of safety across the age spectrum.
Nguyen KL; Yoshida T; Han F; Ayad I; Reemtsen BL; Salusky IB; Satou GM; Hu P; Finn JP
J Magn Reson Imaging; 2017 Mar; 45(3):804-812. PubMed ID: 27480885
[TBL] [Abstract][Full Text] [Related]
5. Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study.
Iv M; Ng NN; Nair S; Zhang Y; Lavezo J; Cheshier SH; Holdsworth SJ; Moseley ME; Rosenberg J; Grant GA; Yeom KW
Radiology; 2020 Nov; 297(2):438-446. PubMed ID: 32930651
[TBL] [Abstract][Full Text] [Related]
6. Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children.
Ruangwattanapaisarn N; Hsiao A; Vasanawala SS
Pediatr Radiol; 2015 Jun; 45(6):831-9. PubMed ID: 25427433
[TBL] [Abstract][Full Text] [Related]
7. Safety of Off-Label Use of Ferumoxtyol as a Contrast Agent for MRI: A Systematic Review and Meta-Analysis of Adverse Events.
Ahmad F; Treanor L; McGrath TA; Walker D; McInnes MDF; Schieda N
J Magn Reson Imaging; 2021 Mar; 53(3):840-858. PubMed ID: 33098154
[TBL] [Abstract][Full Text] [Related]
8. Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults.
Muehe AM; Feng D; von Eyben R; Luna-Fineman S; Link MP; Muthig T; Huddleston AE; Neuwelt EA; Daldrup-Link HE
Invest Radiol; 2016 Apr; 51(4):221-227. PubMed ID: 26656202
[TBL] [Abstract][Full Text] [Related]
9. Impact of ferumoxytol vs gadolinium on 4D flow cardiovascular magnetic resonance measurements in small children with congenital heart disease.
Kollar SE; Udine ML; Mandell JG; Cross RR; Loke YH; Olivieri LJ
J Cardiovasc Magn Reson; 2022 Nov; 24(1):58. PubMed ID: 36352454
[TBL] [Abstract][Full Text] [Related]
10. Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.
Nguyen KL; Yoshida T; Kathuria-Prakash N; Zaki IH; Varallyay CG; Semple SI; Saouaf R; Rigsby CK; Stoumpos S; Whitehead KK; Griffin LM; Saloner D; Hope MD; Prince MR; Fogel MA; Schiebler ML; Roditi GH; Radjenovic A; Newby DE; Neuwelt EA; Bashir MR; Hu P; Finn JP
Radiology; 2019 Dec; 293(3):554-564. PubMed ID: 31638489
[TBL] [Abstract][Full Text] [Related]
11. Safety and technique of ferumoxytol administration for MRI.
Vasanawala SS; Nguyen KL; Hope MD; Bridges MD; Hope TA; Reeder SB; Bashir MR
Magn Reson Med; 2016 May; 75(5):2107-11. PubMed ID: 26890830
[TBL] [Abstract][Full Text] [Related]
12. 4D flow image quality with blood pool contrast: a comparison of gadofosveset trisodium and ferumoxytol.
Mukai K; Burris NS; Mahadevan VS; Foster ED; Ordovas KG; Hope MD
Int J Cardiovasc Imaging; 2018 Feb; 34(2):273-279. PubMed ID: 28884401
[TBL] [Abstract][Full Text] [Related]
13. Brand ferumoxytol vs. generic ferumoxytol comparison across two dosing regimens: a cardiac MRI image quality study.
Dasi A; Kring DN; Selvaraj B; Morgan P; Gerity C; Morgan EE; Krishnamurthy R; Krishnamurthy R
Pediatr Radiol; 2023 Dec; 53(13):2622-2632. PubMed ID: 37837456
[TBL] [Abstract][Full Text] [Related]
14. Accelerated ferumoxytol-enhanced 4D multiphase, steady-state imaging with contrast enhancement (MUSIC) cardiovascular MRI: validation in pediatric congenital heart disease.
Zhou Z; Han F; Rapacchi S; Nguyen KL; Brunengraber DZ; Kim GJ; Finn JP; Hu P
NMR Biomed; 2017 Jan; 30(1):. PubMed ID: 27862507
[TBL] [Abstract][Full Text] [Related]
15. Anaesthesia considerations for cardiac MRI in infants and small children.
Odegard KC; DiNardo JA; Tsai-Goodman B; Powell AJ; Geva T; Laussen PC
Paediatr Anaesth; 2004 Jun; 14(6):471-6. PubMed ID: 15153209
[TBL] [Abstract][Full Text] [Related]
16. How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol.
Daldrup-Link HE; Theruvath AJ; Rashidi A; Iv M; Majzner RG; Spunt SL; Goodman S; Moseley M
Pediatr Radiol; 2022 Feb; 52(2):354-366. PubMed ID: 34046709
[TBL] [Abstract][Full Text] [Related]
17. Combined blood pool and extracellular contrast agents for pediatric and young adult cardiovascular magnetic resonance imaging.
Johnson JT; Robinson JD; Deng J; Rigsby CK
Pediatr Radiol; 2016 Dec; 46(13):1822-1830. PubMed ID: 27576457
[TBL] [Abstract][Full Text] [Related]
18. What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent.
Varallyay CG; Toth GB; Fu R; Netto JP; Firkins J; Ambady P; Neuwelt EA
AJNR Am J Neuroradiol; 2017 Jul; 38(7):1297-1302. PubMed ID: 28495944
[TBL] [Abstract][Full Text] [Related]
19. Ferumoxytol-Enhanced MRI in Children and Young Adults: State of the Art.
Adams LC; Jayapal P; Ramasamy SK; Morakote W; Yeom K; Baratto L; Daldrup-Link HE
AJR Am J Roentgenol; 2023 Apr; 220(4):590-603. PubMed ID: 36197052
[TBL] [Abstract][Full Text] [Related]
20. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
